Who
Kaushik Ghoshal
Director
Company insider
Files Form 4 as: Director, Omnicell; Chief Commercial Officer, SaaS, ResMed.
In numbers
- Trades disclosed
- 66
- Buys
- 0
- Sells
- 11
- Bought
- $0
- Sold
- $10.1M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 11 Nov 2021
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —4,603 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —4,603 at $0.00 | filing |
| 1 Jun 2025filed 3 Jun 2025 | OMCL OmnicellMedical Devices | SEC FORM 4 Code A | —6,401 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —169 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —105 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —5,882 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,589 at $0.00 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $25K169 at $146.34 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $22K105 at $211.76 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $525K3,589 at $146.34 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $1.2M5,882 at $211.76 | filing |
| 10 Mar 2025filed 11 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Sold | $2.3M9,745 at $239.31 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —367 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —3,506 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —514 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedoption or derivative · Medical Devices | SEC FORM 4 Code M | —4,726 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $78K367 at $211.76 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $513K3,506 at $146.34 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $75K514 at $146.34 | filing |
| 3 Mar 2025filed 4 Mar 2025 | RMD ResMedMedical Devices | SEC FORM 4 Code M | $1.0M4,726 at $211.76 | filing |
News
Abbott Laboratories (NYSE:ABT) & ResMed (NYSE:RMD) Head to Head AnalysisRMD · themarketsdaily.com · 8 Oct 2026
0 headlines in the last 90 days name Kaushik Ghoshal; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.